Eurofins Scientific Se Stock Performance
| ERFSF Stock | USD 48.42 0.03 0.06% |
The firm shows a Beta (market volatility) of 1.56, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Eurofins Scientific will likely underperform. At this point, Eurofins Scientific has a negative expected return of -0.0939%. Please make sure to confirm Eurofins Scientific's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Eurofins Scientific performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Eurofins Scientific SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Eurofins Scientific is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 910.5 M | |
| Total Cashflows From Investing Activities | -1 B |
Eurofins |
Eurofins Scientific Relative Risk vs. Return Landscape
If you would invest 5,415 in Eurofins Scientific SE on September 3, 2024 and sell it today you would lose (573.00) from holding Eurofins Scientific SE or give up 10.58% of portfolio value over 90 days. Eurofins Scientific SE is currently producing negative expected returns and takes up 4.0398% volatility of returns over 90 trading days. Put another way, 35% of traded pink sheets are less volatile than Eurofins, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Eurofins Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eurofins Scientific's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Eurofins Scientific SE, and traders can use it to determine the average amount a Eurofins Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0232
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ERFSF |
Estimated Market Risk
| 4.04 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eurofins Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eurofins Scientific by adding Eurofins Scientific to a well-diversified portfolio.
Eurofins Scientific Fundamentals Growth
Eurofins Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Eurofins Scientific, and Eurofins Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eurofins Pink Sheet performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 15.96 B | |||
| Shares Outstanding | 192.56 M | |||
| Price To Earning | 21.61 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 1.95 X | |||
| Revenue | 6.72 B | |||
| EBITDA | 1.7 B | |||
| Cash And Equivalents | 718.8 M | |||
| Cash Per Share | 3.74 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 0.70 % | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 3.63 X | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 187 M | |||
| Current Asset | 1.49 B | |||
| Current Liabilities | 818 M | |||
About Eurofins Scientific Performance
By analyzing Eurofins Scientific's fundamental ratios, stakeholders can gain valuable insights into Eurofins Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Eurofins Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eurofins Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Eurofins Scientific operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 61000 people.Things to note about Eurofins Scientific performance evaluation
Checking the ongoing alerts about Eurofins Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Eurofins Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eurofins Scientific generated a negative expected return over the last 90 days | |
| Eurofins Scientific has high historical volatility and very poor performance | |
| About 33.0% of the company shares are held by company insiders |
- Analyzing Eurofins Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eurofins Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Eurofins Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eurofins Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eurofins Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eurofins Scientific's pink sheet. These opinions can provide insight into Eurofins Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Eurofins Pink Sheet analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |